advertisement
Given that glaucoma is a disease of the central nervous system, there must be greater emphasis and focus on developing intraocular pressure-independent therapies. In addition, scientific research investigating the role of sustained drug delivery is critical for advancing the field. Exciting innovation will require close collaboration and full integration of clinical and basic research efforts. Thus, translational research advances in neuroprotection may lead to future development of truly revolutionary therapies for glaucoma (e.g., neuroregeneration).
Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Conn. Electronic address: james.tsai@yale.edu.
Full article11.8 Neuroprotection (Part of: 11 Medical treatment)